MedPath

University of Virginia

University of Virginia logo
🇺🇸United States
Ownership
Private
Established
1819-01-01
Employees
10K
Market Cap
-
Website
http://www.virginia.edu

Effects of Gait Biofeedback and Impairment-based Rehabilitation in Individuals With Chronic Ankle Instability

Phase 3
Conditions
Ankle Sprains
Ankle Injuries
Interventions
Other: Gait Biofeedback
First Posted Date
2018-04-25
Last Posted Date
2018-05-16
Lead Sponsor
University of Virginia
Target Recruit Count
60
Registration Number
NCT03507803
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Cardiac MRI for Optimal Heart Failure Outcomes With CRT Upgrades

Phase 1
Conditions
Chronic Systolic Heart Failure
Paroxysmal VT
Interventions
Diagnostic Test: MRI prior to de novo CRT
Diagnostic Test: MRI prior to CRT Upgrade
First Posted Date
2018-04-20
Last Posted Date
2018-05-03
Lead Sponsor
University of Virginia
Target Recruit Count
50
Registration Number
NCT03504891
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Interpretation Training to Reduce Anxiety: Evaluating Technology-based Delivery Models and Methods to Reduce Attrition

Phase 2
Completed
Conditions
Anxiety
Interventions
Behavioral: Cognitive Bias Modification - Interpretation training
Behavioral: Online psychoeducation about anxiety
Behavioral: Coaching
First Posted Date
2018-04-17
Last Posted Date
2025-02-19
Lead Sponsor
University of Virginia
Target Recruit Count
1748
Registration Number
NCT03498651
Locations
🇺🇸

MindTrails web site: https://mindtrails.virginia.edu/ (thru Univ. of Virginia), Charlottesville, Virginia, United States

Addressing Mental Health of Cancer Patients and Caregivers Using a Mobile App Suite

Not Applicable
Conditions
Depression
Mental Health Wellness 1
Anxiety
Interventions
Behavioral: IntelliCare + Phone Coaching
First Posted Date
2018-04-05
Last Posted Date
2018-04-05
Lead Sponsor
University of Virginia
Target Recruit Count
50
Registration Number
NCT03488745
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Post-Treatment Surveillance in Lung Cancer

Completed
Conditions
Lung Cancer
First Posted Date
2018-03-23
Last Posted Date
2018-03-23
Lead Sponsor
University of Virginia
Target Recruit Count
9613
Registration Number
NCT03475420

A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy

Phase 1
Completed
Conditions
Metastatic Breast Cancer
Breast Cancer
Interventions
First Posted Date
2018-03-22
Last Posted Date
2022-11-01
Lead Sponsor
University of Virginia
Target Recruit Count
13
Registration Number
NCT03473639
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer

Early Phase 1
Withdrawn
Conditions
Triple Negative Breast Cancer
Interventions
First Posted Date
2018-03-22
Last Posted Date
2024-12-09
Lead Sponsor
University of Virginia
Registration Number
NCT03473691

A Study of the Relationship of Gut Microbial Composition and Stroke Outcome

Conditions
Ischemic Stroke
Interventions
Other: Stool Samples
First Posted Date
2018-03-20
Last Posted Date
2019-11-19
Lead Sponsor
University of Virginia
Target Recruit Count
300
Registration Number
NCT03470506
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

🇺🇸

Inova Health System, Fairfax, Virginia, United States

Mechanisms of Alcohol Sensitivity in AERD

Not Applicable
Conditions
Aspirin-Sensitive Asthma With Nasal Polyps
Samter's Syndrome
Interventions
Dietary Supplement: Water
Dietary Supplement: Red wine
Dietary Supplement: Polyphenolic Compounds
First Posted Date
2018-02-22
Last Posted Date
2018-05-07
Lead Sponsor
University of Virginia
Target Recruit Count
60
Registration Number
NCT03441438
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

CGM Use in Islet Transplant Recipients

Not Applicable
Completed
Conditions
Type1 Diabetes Mellitus
Islet Transplantation
Interventions
Other: Continuous Glucose Monitor (CGM)
First Posted Date
2018-02-09
Last Posted Date
2020-08-07
Lead Sponsor
University of Virginia
Target Recruit Count
7
Registration Number
NCT03427931
Locations
🇺🇸

University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath